(1888PressRelease)
November 07, 2009 - STYL’One, which is the fastest and most versatile machine on the market for the single-punch R&D production of tablets, is primarily designed for use in pharmaceutical research laboratories, but is also suitable for use in the production of food, detergents and cosmetics.
The STYL’One press incorporates the latest technological developments, including a unique patented mechanical design which guarantees precision and robustness under load. The main drive is programmable, offering a range of functionality and versatility that was not previously available. ANALIS, the data-acquisition and control software package supporting the machine, is an open platform featuring the latest technology in data acquisition.
STYL’One has a compression time that is five times faster than similar presses routinely used in R&D facilities, with a minimum time of below 40ms to reach compression peak. This machine can produce and study multilayer tablets at high speed (up to five layers with three powders). The technology for compression is unique and extremely versatile, enabling the user to generate displacement-driven studies (95% of R&D and production tablet presses); force-driven studies (used mainly in R&D and powder characterisation); and a combination of both modes on the same tablet.
In addition, STYL’One offers full control of the dwell time, with extended dwell times allowing users to study the behaviour of tablets maintained under a given level of pressure.
The data-acquisition software developed by Medelpharm collects, visualises, analyses and exports acquired information. The 2009 version of the software can carry out automated studies and is also able to connect with external laboratory apparatus such as scales and hardness testers.
The STYL’One 105ML model with multilayer capabilities, which is designed primarily for the pharmaceutical market, will be available from the second quarter of 2010. Additional functionalities are already under development on the STYL’One platform, including dry coating and larger-than-standard tooling. Medelpharm’s strategy has always been to protect its customers’ investments by making its technological improvement backward-compatible.
The pricing of the STYL’One makes it affordable for the majority of organisations that require multilayer capabilities. Medelpharm aims to make this new machine an industry standard by making some of the unique functionalities already provided by its STYLCAM 200R rotary press simulator more widely available.
The STYL’One tablet press is robust, clean, easy to use and offers fast and simple clean-up. It is made of GMP-approved material and is compliant with most regulatory standards. The machine is compact, measuring 70cmx70cmx180cm and weighing 1100kg, enabling it to be moved easily around a building.
About Medelpharm
Medelpharm, which is headquartered in Bourg-en-Bresse (between Lyons, in south-eastern France, and Geneva, in Switzerland), specialises in powder compression, and offers solutions ranging from R&D to production and maintenance. The company launched its STYLCAM 200R rotary simulator in 2004 and has been entirely dedicated to powder-compression technology since 2007.
Medelpharm has been designated a Young Innovative Company by OSEO, the French Government Research Agency.
Medelpharm has expanded its activities through its use of ‘business angels’ and its 2008 merger with OPTITAB, a powder-compression services company. By carrying out the distribution of QUADRO process equipment for France and RIVA tablet presses for Europe and North Africa, Medelpharm has further expanded its portfolio of technologies for compression.
Medelpharm will take part in the AAPS trade show in Los Angeles (USA) from 9 to 12 November 2009 (Booth 2439).
For further information, please go to: www.medelpharm.com
###
